@article{b60e8813f6374243bceefd3d3615318a,
title = "The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas",
abstract = "GMZ2 is a hybrid protein consisting of the N-terminal region of the glutamate-rich protein fused in frame to the C-terminal region of merozoite surface protein 3 (MSP3). GMZ2 formulated in Al(OH)3 has been tested in 3 published phase 1 clinical trials. The GMZ2/alum formulation showed good safety, tolerability, and immunogenicity, but whether antibodies elicited by vaccination are functional is not known.",
keywords = "Adjuvants, Immunologic, Adult, Aluminum Hydroxide, Antibodies, Protozoan, Child, Preschool, Humans, Immunoglobulin G, Malaria Vaccines, Malaria, Falciparum, Plasmodium falciparum, Vaccines, Synthetic",
author = "Jepsen, {Micha Phill Gr{\o}nholm} and Jogdand, {Prajakta S} and Singh, {Susheel K} and Meral Esen and Michael Christiansen and Saadou Issifou and Hounkpatin, {Aurore B} and Ulysse Ateba-Ngoa and Kremsner, {Peter G} and Dziegiel, {Morten H} and Severin Olesen-Larsen and S{\o}ren Jepsen and Benjamin Mordm{\"u}ller and Michael Theisen",
year = "2013",
month = aug,
day = "1",
doi = "10.1093/infdis/jit185",
language = "English",
volume = "208",
pages = "479--88",
journal = "The Internet Journal of Infectious Diseases",
issn = "1528-8366",
publisher = "Internet Scientific Publications, Llc",
number = "3",
}